Vitamina D3 NM 25.000 UI
funding by the SNS Subject to medical prescription

Vitamina D3 NM 25.000 UI

Initial treatment of clinically significant Vitamin D deficiency in adults.

Presentation and Code

Box of 4 soft capsules

729956.1 PVP9,37 €

It is indicated for the initial treatment of clinically significant vitamin D deficiency in adults.

The dose should be established individually according to the degree of vitamin D supplementation required. The patient’s dietary habits should be carefully evaluated, and the artificially added vitamin D content of certain foods should be taken into account.

Initial treatment of clinically significant vitamin D deficiency (serum levels < 25 nmol/l or < 10 ng/ml) in adults:

  • 1 capsule of 20,000 IU/week for up to 4–5 weeks.
  • 1 capsule of 25,000 IU/week for up to 4 weeks.

After the first month, a lower maintenance dose should be considered depending on the desired serum levels of 25-hydroxycholecalciferol (25(OH)D), the severity of the disease, and the patient’s response to treatment.

  • Cholecalciferol (Vitamin D3).
  • Each soft capsule contains 0.625 milligrams of cholecalciferol (equivalent to 25,000 IU).